gip/glp-1 tirzepatide (TZP) differentially induces internalization of the GIP and Pharmacogenomics of Tirzepatide: Genomic Insights

These compounds vary in chemical structure, pharmacokinetics and size, which results in different clinical effects on hyperglycaemia and body weight loss

A self-funded employer can carve out weight-loss drugs entirely, leaving the Humana formulary intact but with a benefit exclusion

Characteristics of therapeutic GLP-1R agonists Endogenous GLP-1 is characterized by a very short half-life of only few minutes, as it is quickly degraded by dipeptidyl peptidase-4 (DPP4), an enzyme expressed in many different types of tissues

Patients no longer need to worry about self-injecting or disposing of needles, making it easier to integrate these medications into their daily routines